Mode
Text Size
Log in / Sign up
Phase 2 N=11 Treatment

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

Primary Progressive Aphasia

Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Percentage of Participants Who Complete 16 Out of 20 Study Visits — 100 percentage of participants

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Transcranial Direct Current Stimulation (tDCS) (Device); Word-Naming Activity (Behavioral)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
NYU Langone Health
Primary completion
Aug 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Who Complete 16 Out of 20 Study Visits
100
SECONDARY
Number of Trained Language Probes at Treatment End
25.1
SECONDARY
Number of Untrained Language Probes at Treatment End
20.2
SECONDARY
Change in Aphasia Communication Outcome Measure (ACOM) Score
0.74
SECONDARY
Change in Stroke and Aphasia Quality of Life-39 Item (SAQOL-39) Score
-0.07
SECONDARY
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) - Social Roles and Activities Score
-1.2
SECONDARY
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) - Global Health Score
0.87
SECONDARY
Change in Quick Aphasia Battery (QAB) Score
0.14
SECONDARY
Change in Boston Naming Test (BNT)-Short Form Score
1.6
SECONDARY
Change in Controlled Oral Word Association Test (COWAT) Score
1.4

Summary

The purpose of this study is to establish the feasibility of a program of remotely supervised transcranial direct current stimulation (RS-tDCS) paired with language skills practice for people living with the semantic or logopenic variants of primary progressive aphasia (PPA). There are currently no established standard-of-care treatments for PPA. This study will evaluate whether RS-tDCS combined with language skills practice is a feasible study design for individuals with PPA.

Eligibility Criteria

Inclusion Criteria

  • Primary progressive aphasia diagnosis (logopenic or semantic variant)
  • Peabody Picture Vocabulary Test (PPVT) score < -1.0 SD, serving as a literacy proxy for premorbid cognitive ability and ensuring English language fluency sufficient for participation in the study procedures.
  • WAIS-IV Matrix Reasoning T score < 20, serving as an index of current general cognitive functioning to exclude those with severe cognitive impairment
  • Stable and continuous access to internet service, email (WiFi "hotspot" to be provided if needed)
  • Fluent in English language (due to outcomes validated in English versions only)

Exclusion Criteria

  • Disorder other than PPA known to cause language dysfunction
  • Diagnosis of nonfluent/agrammatic subtype of primary progressive aphasia
  • History of traumatic brain injury
  • Uncontrolled seizure disorder and/or recent (<5 years) history of seizure
  • Metal implants in the head or neck
  • Any skin disorder or skin sensitive area near stimulation locations
  • Pregnant or breastfeeding
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05615922). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search